Breast Neoplasms
Conditions
Interventions
This is an uncontrolled, single-center clinical trial with a follow-up period of 24 weeks. The study population consists of women treated for breast cancer and volunteers residing in Rio Claro, São Pa
values above 88 cm are classified as increased. Bioelectrical impedance analysis (BIA) is used to assess body composition (InBody 770, Korea). Quality of Life, Sleep, Mindfulness/Attentiveness, and St
Sleep using the Epworth Sleepiness Scale
Attentiveness using the Mindful Attention Awareness Scale (MAAS)
and Stress using the Perceived Stress Scale. During the 24-week intervention, the group participates in structured group classes on healthy nutrition conducted by nutritionists and the multidisciplina
Sponsors
Departamento de Ginecologia e Obstetrícia
Departamento de Ginecologia e Obstetrícia
Eligibility
Sex/Gender
Female
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Women, aged between 45 and 75 years, with a histological diagnosis of breast cancer who had undergone sentinel axillary lymph node biopsy or axillary lymphadenectomy; who had completed cancer treatment (chemotherapy and/or radiotherapy), except for hormone therapy; clinical stage I, II, or III; and the ability to understand and consent to participate in the study.
Exclusion criteria
Exclusion criteria: Women with stage IV and/or metastatic disease; alcohol or drug users; clinical lymphedema of the upper limb; athletes; neurological, musculoskeletal, or other conditions limiting participation in a regular physical exercise program; or carriers of a cardiac pacemaker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An improvement in quality of life is expected, as assessed by the DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaire and the EORTC QLQ-C30 (30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvements are expected in body composition and anthropometric data, assessed through bioimpedance, body mass index and measurements of calf circumference;Improvements are expected in upper limb dysfunctions, such as pain, assessed using a 0–10 visual analog scale; shoulder range and speed of motion,evaluated by goniometry and a digital device called BIOBIT; handgrip strength, assessed using a handgrip dynamometer; and upper limb volumetry, evaluated by clinical circumference measurements converted into volume using the truncated cone formula;Improvements are expected in functional mobility related to fall risk, assessed by the Timed Up and Go test;Improvements are expected in perceived stress, sleep quality, and attentiveness, assessed by the Perceived Stress Scale (PSS-10), the Epworth Sleepiness Scale, and the Mindful Attention Awareness Scale;Improvements are expected in metabolic health, assessed through blood pressure measurement, waist circumference, and blood tests analyzing fasting glucose, fasting insulin, triglycerides, total cholesterol, and its fractions | — |
Countries
Brazil
Contacts
Public ContactSamantha Karlla Rizzi
Universidade Federal de São Paulo
Outcome results
None listed